• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Enzymatic detoxification using lipophilic hollow-fiber membranes: I. Glucuronidation reactions.

作者信息

Brunner G, Tegtmeier F

出版信息

Artif Organs. 1984 May;8(2):161-6. doi: 10.1111/j.1525-1594.1984.tb04266.x.

DOI:10.1111/j.1525-1594.1984.tb04266.x
PMID:6428386
Abstract

A lipophilic hollow-fiber membrane preparation was used in the enzymatic detoxification of lipophilic toxins. Native enzymes were circulated on one side of the lipophilic membrane, while the toxin-containing media (blood, serum, waste fluids, etc.) were circulated inside the hollow fiber. Lipophilic substances that accumulate in and penetrate the lipophilic membrane were converted by the corresponding enzymes. Phase II detoxifying enzymes converted the lipophilic toxins to hydrophylic compounds that made a rediffusion of these molecules back to the blood impossible. Glucuronidation reactions were catalyzed by a crude preparation of solubilized uridine-5'-diphosphate-glucuronyltransferase (EC 2.1.1.9) with a specific activity of 10.0 nmol/min/mg protein in the presence of uridine-5'- diphosphoglucuronic acid (acceptor: phenol as reference substrate). Clearance rates of phenol, 1- naphthol , 2- naphthol , and p-cresol were measured, respectively, to be 141, 195, 300, and 251 pmol/h/mg protein/cm2 hollow fiber. The advantage of this technique lies in the possibility of using highly active, soluble enzyme preparations and a fully utilizable cofactor supply. The lipid membrane ensures the absence of immunological hazards, while mass transfer of the toxin is not impaired.

摘要

相似文献

1
Enzymatic detoxification using lipophilic hollow-fiber membranes: I. Glucuronidation reactions.
Artif Organs. 1984 May;8(2):161-6. doi: 10.1111/j.1525-1594.1984.tb04266.x.
2
Enzymatic detoxification using lipophilic hollow-fiber membranes: II. Sulfation reactions.使用亲脂性中空纤维膜的酶促解毒作用:II. 硫酸化反应。
Artif Organs. 1985 Feb;9(1):37-41. doi: 10.1111/j.1525-1594.1985.tb04344.x.
3
Enzymatic detoxification using lipophilic hollow-fiber membranes: III. Oxidation reactions of sulfides.使用亲脂性中空纤维膜的酶促解毒:III. 硫化物的氧化反应。
Artif Organs. 1989 Apr;13(2):103-8. doi: 10.1111/j.1525-1594.1989.tb02844.x.
4
Enzymatic detoxification using lipophilic hollow-fiber membranes: IV. Glutathione conjugation reactions.
Int J Artif Organs. 1989 Feb;12(2):121-8.
5
A membrane transporter mediates access of uridine 5'-diphosphoglucuronic acid from the cytosol into the endoplasmic reticulum of rat hepatocytes: implications for glucuronidation reactions.一种膜转运蛋白介导尿苷5'-二磷酸葡萄糖醛酸从细胞质溶胶进入大鼠肝细胞的内质网:对葡萄糖醛酸化反应的影响。
Biochim Biophys Acta. 1988 Nov 17;967(2):149-57. doi: 10.1016/0304-4165(88)90004-9.
6
Examination of the substrate specificity of cloned rat kidney phenol UDP-glucuronyltransferase expressed in COS-7 cells.
Mol Pharmacol. 1988 Nov;34(5):638-42.
7
[Progress on the way to an "artificial liver"].["人工肝之路的进展"]
Leber Magen Darm. 1984 Nov;14(6):276-81.
8
Uridine diphosphate-glucuronosyltransferase activities in rat brain microsomes.大鼠脑微粒体中的尿苷二磷酸葡萄糖醛酸基转移酶活性
Neurosci Lett. 1993 Oct 29;161(2):219-22. doi: 10.1016/0304-3940(93)90298-y.
9
Quantitative structure-activity relationships of the metabolism of drugs by uridine diphosphate glucuronosyltransferase.尿苷二磷酸葡萄糖醛酸转移酶对药物代谢的定量构效关系
J Pharm Sci. 1991 Oct;80(10):966-70. doi: 10.1002/jps.2600801013.
10
Stimulation of microsomal uridine diphosphate glucuronyltransferase by glucuronic acid derivatives.葡萄糖醛酸衍生物对微粒体尿苷二磷酸葡萄糖醛酸基转移酶的刺激作用。
Biochem J. 1974 Apr;139(1):243-9. doi: 10.1042/bj1390243.

引用本文的文献

1
Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients.人工和生物人工肝支持:肝衰竭患者灌注治疗综述
World J Gastroenterol. 2007 Mar 14;13(10):1516-21. doi: 10.3748/wjg.v13.i10.1516.
2
Development and perspectives of perfusion treatment for liver failure.肝衰竭灌注治疗的发展与展望
Surg Today. 2005;35(7):507-17. doi: 10.1007/s00595-004-2980-5.